Overview and Usage

Medicine Details

Brand nameErlocip
ManufacturerCipla pharma
Dosage FormTablet
Route of AdministrationOral
Strength100, 150mg
StorageStore at room temperature (10-30°C)
Indicationnon-small cell lung cancer (NSCLC) and pancreatic cancer
Class of DrugKinase inhibitor


It is the study of drug effects and what the medicine does to the body

It inhibits the intracellular phosphorylation of tyrosine kinase associated with epidermal growth factor (EGFR). The specificity of inhibition concerning other tyrosine kinase receptors has not been fully characterized. EGFR is also expressed on the cell surface of normal cells and cancer cells


Study of what the body does to the medicine. Erlocip is around 60% absorbed after administration into the body and its bioavailability is increased by food to almost 100%. Its half-life is 36 hours and it is cleared majorly by the CYP3A4 enzyme present in the body.

Minimum effect concentration (MEC)

A minimum concentration of medicine in the blood is required to produce therapeutic effects. Its predefined therapeutic MEC is (0.8μg/ml)

Minimum toxic concentration (MTC)

Minimum concentration of medicine in blood above which toxic or adverse effects are precipitated. Its MTC is 1.25μg/ml

Bioavailability Rate Of Erlocip

After oral administration, the medicine archived approximately 60% bioavailability, with the administration of food enhancing bioavailability to upwards of 100%

The Shelf Life Of Erlocip

Shelf life is the period over which the concentration of the active medicinal ingredient in the formulation lowers by 10 percent from its value at the time of manufacture.

Erlocip 150mg- 30 Months

Erlocip 100mg- 2 Years

Mechanism of Action

It belongs to a class of medications called kinase inhibitors. It works by blocking the action of abnormal protein that signals cancer cells to multiply. This in turn helps to slow or inhibit the spread of cancer cells


Which disease area
Non-small cell lung cancer (NSCLC) and pancreatic cancer


  • Tarceva
  • Carac

Alternate Brands

  • Erlonat 150mg Tablet by NATCO.
  • Erlotib 150mg Tablet by Intas.
  • Zyceva 150mg Tablet by Zydus.
  • Erleva 100 mg/150 mg by Glenmark.
  • Erlotirel 100 mg/150 mg by Reliance Life Sciences.

Side Effects Of Erlotinib 150mg Tablet

    Common Side Effects

  • Abdominal pain
  • Bone pain
  • Breathlessness
  • Constipation
  • Cough
  • Diarrhea
  • Fatigue
  • Fever
  • Infection
  • Muscle pain
  • Nausea
  • Rash
  • Stomatitis (Inflammation of the mouth)
  • Vomiting
  • Weight loss

Serious Side Effects Erlocip

Fatigue, loss of appetite, partial hair loss, diarrhea, mouth sores, vomiting, rashes, weight loss, dry skin, eye irritation, weight decrease, infection, edema, pyrexia, constipation, bone pain, dyspnea, stomatitis, and myalgia.

Dosage Of Erlocip

Missed Dose

If the patient misses a dose of medicine, skip it and continue with the normal schedule. No need to double the dose


Get the emergency medical treatment and contact your physician

Warnings Of Erlocip

    General Warning And Precautions

The medicine causes skin rash, dryness, or other irritation. Wear protective clothing and use sunscreen (SPF 30 or higher) when you are outdoors.

Stop using skin products that cause dryness or irritation, such as acne medications, harsh soaps or skin cleansers, or skin products that have alcohol.


It is usually taken on an empty stomach once a day, at least 1 hour before or 2 hours after eating a meal or snack. Take erlocip at around the same time every day.


Consult your doctor before taking this medicine, if you:

Are allergic to ERLOCIP 150MG, or any of the ingredients of this medicine, or having severe liver disease or severe kidney disease

If one uses contact lenses and/or has a history of eye problems such as severe dry eyes